1The effectiveness of hydrotherapy on quality of life and exercise capacity in patients with cardiac diseases: a scoping review.2026 · Europe PMC
2Therapeutic Modulation of Nitric Oxide Pathways to Address Insulin Resistance in Cardiovascular-Kidney-Metabolic Syndrome.2026 · Europe PMC
3Science policies and practice of including and excluding women from clinical studies: focus on cardiovascular research.2026 · Europe PMC
4Beyond Inflammation: The Th1/Th17-Treg Axis as an Emerging Immune Signature of Atrial Fibrillation in Asians.2026 · Europe PMC
5Multi-Organ Crosstalk in HFpEF: Reframing a Cardiac Syndrome as a widespread Systemic Disease.2026 · Europe PMC
6Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial2026 · Europe PMC
7Ursodeoxycholic acid as a potential cardioprotective agent: molecular mechanisms, experimental evidence, and clinical perspectives.2026 · Europe PMC
9Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology.2026 · Europe PMC
10Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.2026 · Europe PMC
11Advanced quantitative CT for coronary artery disease: integrating stenosis quantification, plaque quantification, and fractional flow reserve-CT.2026 · Europe PMC
12High-dose quadrivalent influenza vaccine in older adults with or without cardiovascular risk: a meta-analysis of randomized trials on 511,890 participants.2026 · Europe PMC
13Safety and efficacy of low-density lipoprotein-lowering drugs in the elderly: a network meta-analysis of randomized controlled trials.2026 · Europe PMC
14Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review.2026 · Europe PMC
18Exploring the Pleiotropic Cardioprotective Effects of GLP-1 Receptor Agonists in Preventing Anthracycline-Induced Cardiotoxicity: A Theoretical Proposal for Future Research.2026 · Europe PMC
19Mitochondrial Quality Control Links Exercise to Sterile Inflammation in the Cardiovascular System: A Narrative Review.2026 · Europe PMC
20Cardiac safety profiles of first-generation vs second-generation BTK inhibitors: a meta-analysis.2026 · Europe PMC
21Effect of Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists on Myocardial Infarction and Stroke in Type 2 Diabetes: A Systematic Review and Meta-Analysis.2026 · Europe PMC
22Clinical trials in a dish: cardiometabolic drug development with biological and digital twins.2026 · Europe PMC
23Repurposing of colchicine: critical examination of clinical trials and scoping review.2026 · Europe PMC
24Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial.2026 · Europe PMC
26Yoga and Mindfulness-Based Rehabilitation After Myocardial Infarction: A Systematic Review.2026 · Europe PMC
27Cardiovascular Disease Screening Programs in Low- and Middle-Income Countries: A Systematic Review.2026 · Europe PMC
28Strategies to improve adherence to exercise-based phase II cardiac rehabilitation after percutaneous coronary intervention: a best evidence summary.2026 · Europe PMC
29Phase I clinical trials for cardiovascular diseases in Europe: analysis of trends, distribution, and regulatory context.2026 · Europe PMC
30NLRP3-mediated pyroptosis in cardiovascular disease: from molecular mechanisms to therapeutic targets.2026 · Europe PMC
31The enduring value of single-center studies in the era of big data: A message to early career pediatric cardiologist.2026 · Europe PMC
33A Comprehensive Meta-Analysis of the Cardiovascular Adverse Effects of Bispecific Antibody Therapy in Hematologic Malignancies.2026 · Europe PMC
34The role of lipid lowering medications in the primary prevention of cardiovascular disease and mortality: a meta-analysis of randomized controlled trials.2026 · Europe PMC
35Metabolic-epigenetic axis in cardiovascular inflammatory injury: regulatory mechanisms and intervention strategies.2026 · Europe PMC
36Mortality and Cardiovascular Outcomes Associated with Statin Use in Dialysis Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.2026 · Europe PMC
37Digital health solutions for chronic disease physical activity management: wearable devices, artificial intelligence, and public health implementation.2026 · Europe PMC
38A Review of Clinical Trial and Meta-Analyses of BP Treatment Strategies for Patients with Orthostatic Hypotension: Blood Pressure Management in Patients with Hypertension and Orthostatic Hypotension.2026 · Europe PMC
39Beyond valve replacement: integrating structural intervention and optimal medical therapy for better long-term outcomes.2026 · Europe PMC
40Contemporary medical therapy for heart failure with mildly reduced or preserved ejection fraction.2026 · Europe PMC
41Aspirin in Primary Prevention of CVD: A Pragmatic Outline and Advice for Treatment Personalization.2026 · Europe PMC
42Sex Differences in the Impact of Physical Activity Across the Spectrum of Cardiovascular Disease.2026 · Europe PMC
43Epigenetic Mechanisms in Perioperative Medicine: From Neuroinflammation and NETosis to Organ Dysfunction and Precision Therapeutics.2026 · Europe PMC
45Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, CAR-T, and bispecific antibodies.2026 · Europe PMC
46From obesity to cardiovascular disease: pathological basis and clinical implications.2026 · Europe PMC
48To B-E3 or Not to B-E3: The Roles of MuRF1 and Junctophilin-2 in Junctin Regulation.2026 · Europe PMC
49Metabolic reprogramming in chronic kidney disease-cardiovascular disease comorbidity: from molecular mechanisms to therapeutic strategies.2026 · Europe PMC
51Association between periodontitis and heart failure: Mechanisms and clinical implications (Review).2026 · Europe PMC
52Use of the Teach-Back Method in Adults with Cardiovascular Disease: A Scoping Review.2026 · Europe PMC
53Colchicine in Cardiovascular Disease: Evidence Structure, Clinical Efficacy, Safety, and Translational Positioning Across Cardiovascular Syndromes.2026 · Europe PMC
54AI-driven biological clocks of cardiac aging: Should we integrate ECG, metabolomic, and epigenetic signatures?2026 · Europe PMC
56Implementation and Strategies to Support Adoption of the World Heart Federation Roadmap on Cardiac Rehabilitation: A Pathway to Improve Lifelong Cardiovascular Health.2026 · Europe PMC
58Prognostication and clinical opportunities with AI for coronary artery calcium: a scoping review.2026 · Europe PMC
60Visceral adiposity and cardiovascular risk in the era of cardiovascular-kidney-metabolic syndrome.2026 · Europe PMC